Breaking Genesis AI raises $500 million Series A at $3.5 billion valuation 3 sources · since 9:00 AM EST (42 min ago) · +1 more breaking
How it works

WhatsNewPaper

← Back to the front page
Unverified

Gathered automatically from the outlets below; our newsroom hasn't checked it yet.

DNA drug developer Seawolf launches with $100 million funding, Sanofi deal

Seawolf Therapeutics on Monday launched publicly with $100 million in funding and a deal with French drugmaker Sanofi worth ​up to $1.2 billion, as it seeks to ‌develop DNA-based medicines.